CU20100036A7 - IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME - Google Patents

IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME

Info

Publication number
CU20100036A7
CU20100036A7 CU20100036A CU20100036A CU20100036A7 CU 20100036 A7 CU20100036 A7 CU 20100036A7 CU 20100036 A CU20100036 A CU 20100036A CU 20100036 A CU20100036 A CU 20100036A CU 20100036 A7 CU20100036 A7 CU 20100036A7
Authority
CU
Cuba
Prior art keywords
lactamide
compound
formula
morpholinyl
hydroxyethyl
Prior art date
Application number
CU20100036A
Other languages
Spanish (es)
Inventor
Ian David Tovey
Clair Louise Harris
Gordon Alastair Bell
Original Assignee
Syngenta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Ltd filed Critical Syngenta Ltd
Priority to CU20100036A priority Critical patent/CU20100036A7/en
Publication of CU20100036A7 publication Critical patent/CU20100036A7/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Una composición que comprende un compuesto de fórmula (I) CH3CH(OH)C(=O)NR1R2 (I) donde R1 y R2 son cada uno independientemente hidrógeno; o alquilo C1-6, alquenilo C2-6 o cicloalquilo C3-6, cada uno de los cuales está opcionalmente sustituido con hasta tres sustituyentes seleccionados independientemente entre fenilo, hidroxi, alcoxi C1-5, morfolinilo y NR3R4 donde R3 y R4 son cada uno independientemente alquilo C1-3; o fenilo opcionalmente sustituido con hasta tres sustituyentes seleccionados independientemente entre alquilo C1-3; o R1 y R2 junto con el átomo de nitrógeno al cual están unidos forman un anillo morfolinilo, pirrolidinilo, piperidinilo o azepanilo, cada uno de los cuales está opcionalmente sustituido con hasta tres sustituyentes seleccionados independientemente entre alquilo C1-3; y por lo menos un compuesto biológicamente activo, el cual comprende por lo menos un anillo aromático de cinco y/o seis miembros donde el anillo contiene por lo menos un nitrógeno como un miembro del anillo, con las siguientes condiciones: (i) que la composición no contenga ciproconazol cuando el compuesto de fórmula 1 se selecciona del grupo formado por N-butoxipropil-lactamida; 1-(hidroxietil)piperidinil-lactamida; N-metil-N-propil-lactamida; N-(1-etilpropil)-lactamida; N,N-dimetil-lactamida; N-1,4-dimetilpentil-lactamida; N-(2-hidroxietil)-N-bencil-lactamida; N-Morfolinil-lactamida; N-metil-N-butil-lactamida; N-Isobutil-lactamida; N-Alil-lactamida; N-Etil-lactamida; N-Etil-N-(2-hidroxietil)-lactamida; y N-isopropil-lactamida; y (ii) que el compuesto biológicamente activo no sea ácido nicotínico cuando el compuesto de fórmula 1 es dietil-lactamida. Dichas composiciones pueden ser, o pueden estar compuestas por, concentrados en emulsión, particularmente en el caso de que el compuesto de fórmula 1 sea dimetil-lactamida y el compuesto biológicamente activo sea el fungicida (9-isopropil-1,2,3,4-tetrahidro-1,4-metano-naftalen-5-il)-amida del ácido 3-difluormetil-1-metil-1H-pirazol-4-carboxílico que se muestra en la figura 2.A composition comprising a compound of formula (I) CH3CH (OH) C (= O) NR1R2 (I) wherein R1 and R2 are each independently hydrogen; or C1-6 alkyl, C2-6 alkenyl or C3-6 cycloalkyl, each of which is optionally substituted with up to three substituents independently selected from phenyl, hydroxy, C1-5 alkoxy, morpholinyl and NR3R4 where R3 and R4 are each independently C1-3 alkyl; or phenyl optionally substituted with up to three substituents independently selected from C1-3 alkyl; or R1 and R2 together with the nitrogen atom to which they are attached form a morpholinyl, pyrrolidinyl, piperidinyl or azepanyl ring, each of which is optionally substituted with up to three substituents independently selected from C1-3alkyl; and at least one biologically active compound, which comprises at least one aromatic ring of five and / or six members where the ring contains at least one nitrogen as a member of the ring, with the following conditions: (i) that the composition does not contain cyproconazole when the compound of formula 1 is selected from the group consisting of N-butoxypropyl-lactamide; 1- (hydroxyethyl) piperidinyl lactamide; N-methyl-N-propyl-lactamide; N- (1-ethylpropyl) -lactamide; N, N-dimethyl-lactamide; N-1,4-dimethylpentyl-lactamide; N- (2-hydroxyethyl) -N-benzyl-lactamide; N-Morpholinyl Lactamide; N-methyl-N-butyl lactamide; N-Isobutyl-lactamide; N-Alyl-lactamide; N-Ethyl-lactamide; N-Ethyl-N- (2-hydroxyethyl) -lactamide; and N-isopropyl-lactamide; and (ii) that the biologically active compound is not nicotinic acid when the compound of formula 1 is diethyl-lactamide. Such compositions may be, or may be composed of, emulsion concentrates, particularly in the case where the compound of formula 1 is dimethyl-lactamide and the biologically active compound is the fungicide (9-isopropyl-1,2,3,4 3-Difluoromethyl-1-methyl-1 H -pyrazol-4-carboxylic acid tetrahydro-1,4-methane-naphthalen-5-yl) -amide shown in Figure 2.

CU20100036A 2010-02-22 2010-02-22 IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME CU20100036A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20100036A CU20100036A7 (en) 2010-02-22 2010-02-22 IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20100036A CU20100036A7 (en) 2010-02-22 2010-02-22 IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME

Publications (1)

Publication Number Publication Date
CU20100036A7 true CU20100036A7 (en) 2011-10-05

Family

ID=45000064

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100036A CU20100036A7 (en) 2010-02-22 2010-02-22 IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME

Country Status (1)

Country Link
CU (1) CU20100036A7 (en)

Similar Documents

Publication Publication Date Title
ECSP109990A (en) IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME
NO20083435L (en) formulations
ES2531274T3 (en) Oxazole-substituted indazoles as inhibitors of PI3-kinases
AR030762A1 (en) PYRIDINILAMIDS AND IMIDES TO USE AS FUNGICIDES
CO6351734A2 (en) USEFUL AMIDA COMPOUNDS IN THERAPY
NI201000027A (en) IMPROVEMENTS IN OR RELATED TO ORGANIC COMPOUNDS
UY32606A (en) NEMATOCID SULPHONAMIDS
ECSP099559A (en) Fungicidal mixtures comprising 1-methylpyrazol-4-ylcarboxanilides
ECSP088397A (en) USEFUL HETEROCICLIC DERIVATIVES AS MICROBIOCIDES
AR080841A1 (en) DERIVATIVES OF REPLACED ISOXAZOLINE; VETERINARY COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF PARASITES IN ANIMALS
ES2531056T3 (en) Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
AR053994A1 (en) SULFONYLPIRROLIDINAS REPLACED PROCEDURE FOR PREPARATION AND USE AS MEDICATIONS
PE20070041A1 (en) PYRAZOLCARBOXYL ACID AMIDES
CO5550397A2 (en) ORTO-CICLOPROPIL-TIENIL-CARBOXAMIDAS WITH FUNGICIDE ACTIVITY
AR073008A1 (en) 2-AMINOPIRIMIDINE COMPOUNDS AS POWERFUL INHIBITORS OF HSP-90
CU20100036A7 (en) IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME
AR070737A1 (en) PROCESS FOR THE PREPARATION OF (PHENYLSULPHANYLFENYL) PIPERIDINS
CU20100037A7 (en) IMPROVEMENTS IN ORGANIC COMPOUNDS OR RELATED TO THE SAME
PY2222107A (en) FORMULATION
AR066259A1 (en) PROCESS FOR OBTAINING ACID CHLORIDES
AR073285A1 (en) IMIDAZOL AND TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS ANTIMICOTIC
MX2012008377A (en) Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application.
AR052243A1 (en) DERIVATIVES OF N - [(3S) -PIRROLIDIN-3-IL] -BENZAMIDA, USEFUL AS INHIBITORS OF MONOAMINE RECAPTATION